That's great you're following the latest research! For Dravet syndrome (DS), I've seen some promising updates. Researchers are exploring gene therapies and other targeted interventions that could reduce seizures and even alleviate autism symptoms.

One exciting development is Zorevunersen, an antisense oligonucleotide. Data shows it may reduce seizures and improve behavior, cognition, and quality of life. There's also the Emperor study, a Phase 3 trial, that you can learn about at emperorstudy.com.

Studies also suggest that low doses of Clonazepam may alleviate autistic-like behaviors, and that targeting VIP interneuron dysfunction could be a therapeutic target. It's encouraging to see progress in understanding and treating the autism-related aspects of Dravet!